Evidence map›Paper›PMID 35462926›Full record

ArticleFrontiers in pharmacology2022

Impact of the

Jianqiao Chen, Jin Zheng, Zifan Zhu, Benchuan Hao, Miao Wang, Huiying Li, Yulun Cai, Shiqi Wang, Jun Li, Hongbin Liu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. CYP2D6 Metabolizer Status and Mortality in Metoprolol Users.Clinical and translational science · 2026
    Article
  2. Article
  3. Article
  4. Metoprolol andJournal of personalized medicine · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Jianqiao ChenDepartment of Cardiology, the Second Medical Center and National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, China.
Jin ZhengDepartment of Cardiology, the Second Medical Center and National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, China.
Zifan ZhuDepartment of Cardiology, the Second Medical Center and National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, China.
Benchuan HaoDepartment of Cardiology, the Second Medical Center and National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, China.
Miao WangThe School of Medicine, Nankai University, Tianjin, China.
Huiying LiDepartment of Cardiology, the Second Medical Center and National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, China.
Yulun CaiDepartment of Cardiology, the Second Medical Center and National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, China.
Shiqi WangGeneral Department of Zhengzhou First People's Hospital, Zhengzhou, China.
Jun LiMedical School of Chinese PLA, Beijing, China.
Hongbin LiuDepartment of Cardiology, the Second Medical Center and National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, China.
PLA Academy of Military Science · CNChinese PLA General Hospital · CNNankai University · CNZhengzhou People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The latest consensus has changed

Indexed as

adverse eventscardiovascular diseaseCYP2D6drug tolerancemaintenance dosemetoprololpharmacogeneticsthe elderly

Identifiers

PMID35462926
PMCPMC9019718
OpenAlexW4226134063

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.